Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2011
07/28/2011US20110182889 Compositions and methods for the treatment of natural killer cell related diseases
07/28/2011US20110182887 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
07/28/2011US20110182880 Combination Therapies Against Cancer
07/28/2011US20110182878 Anti-Ricin Antibody
07/28/2011US20110182875 Novel class of therapeutic protein based molecules
07/28/2011US20110182870 Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
07/28/2011US20110182868 Human lysosomal proteins from plant cell culture
07/28/2011US20110182867 Modulation of bcl11a for treatment of hemoglobinopathies
07/28/2011US20110182848 Granulocyte colony stimulating factor
07/28/2011US20110180425 Devices and methods for biochip multiplexing
07/28/2011DE112009002213T5 Transgene Pflanzen mit erhöhtem Ertrag Transgenic plants with increased yield
07/28/2011DE112009001405T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation
07/28/2011DE102010000168A1 Hydroxylating and/or epoxidizing terpenoids e.g. geraniol, comprises adding a polypeptide to a reaction medium, optionally adding an electron transfer partner, adding terpenoids to be hydroxylated to the mixture, incubating, and extracting
07/28/2011DE102008004253B4 Gesteigerte Produktion von Acetyl-Coenzym A Increased production of acetyl-coenzyme A
07/28/2011DE102006041455B4 Verfahren zur Herstellung einer einen stabilisierten funktionellen humanen Einzelketten-Antigen-erkennenden-TCR (scTCR) exprimierenden Zelllinie, damit hergestellt Zelllinie, stabilisierter TAA-spezifischer scTCR, deren Verwendungen und diese enthaltende pharmazeutische Zusammmensetzungen A method for preparing a stabilized functional human single-chain antigen-recognizing TCR (scTCR) expressing cell line, thus established cell line, stabilized TAA-specific scTCR, their uses and pharmaceutical containing them Zusammmensetzungen
07/28/2011CA2825187A1 Improved methods and compositions for determining the pathogenic status of infectious agents
07/28/2011CA2788074A1 Methods of intracellular conversion of single-chain proteins into their di-chain form
07/28/2011CA2787974A1 Immunogenic influenza composition
07/28/2011CA2787698A1 Methods for manufacturing plant cell walls comprising chitin
07/28/2011CA2787677A1 Methods and compositions for displaying a poypeptide on a yeast cell surface
07/28/2011CA2787674A1 Excision of transgenes in genetically modified organisms
07/28/2011CA2787639A1 Methods and kits for isolating nucleic acid from an organism
07/28/2011CA2787594A1 Engineered landing pads for gene targeting in plants
07/28/2011CA2787494A1 Targeted genomic alteration
07/28/2011CA2787344A1 Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
07/28/2011CA2787327A1 Probes for detecting the presence of trichomonas vaginalis in a sample
07/28/2011CA2786766A1 Methods for intracellular delivery of nucleic acids
07/28/2011CA2786568A1 Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
07/28/2011CA2786464A1 Novel centromeres and methods of using the same
07/28/2011CA2786357A1 Simultaneous determination of aneuploidy and fetal fraction
07/28/2011CA2785971A1 Production of heterologous polypeptides in microalgae, microalgal extracellular bodies, compositions, and methods of making and uses thereof
07/28/2011CA2785653A1 Recombinant ndv antigen and uses thereof
07/28/2011CA2785432A1 Male and female sterility lines used to make hybrids in genetically modified plants
07/28/2011CA2785177A1 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
07/28/2011CA2785173A1 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
07/28/2011CA2784903A1 Alcohol dehydrogenases (adh) useful for fermentive production of lower alkyl alcohols
07/28/2011CA2784148A1 Sorghum fertility restorer genotypes and methods of marker-assisted selection
07/27/2011EP2348135A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours
07/27/2011EP2348134A1 RNA interference mediating small RNA molecules
07/27/2011EP2348133A1 RNA interference mediating small RNA molecules
07/27/2011EP2348125A2 Method for the synthesis of a bifunctional complex
07/27/2011EP2348124A2 Synthesis of a bifunctional complex
07/27/2011EP2348119A2 Multicistronic lentiviral vector
07/27/2011EP2348118A1 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
07/27/2011EP2348117A1 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use
07/27/2011EP2348116A2 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar
07/27/2011EP2348115A2 Transgenic plant-based methods for plant pests using RNAi
07/27/2011EP2348114A1 Bone delivery conjugates and method of using same to target proteins to bone
07/27/2011EP2348113A2 Microbial production of L-ascorbic acid
07/27/2011EP2348112A2 Stabilized immune modulatory RNA (SIMRA) compounds
07/27/2011EP2348111A1 PROBES FOR DETECTING MUTATIONS OF kRas GENE, LIQUICHIP AND DETECTION METHODS THEREOF
07/27/2011EP2348110A1 Process
07/27/2011EP2348109A1 Genes having activity of promoting endoreduplication
07/27/2011EP2348108A1 Flavin-bound glucose dehydrogenase
07/27/2011EP2348107A2 Method for preparing evolved micro-organisms, enabling the creation or modification of metabolic pathways
07/27/2011EP2348053A2 Oligopeptide ligands
07/27/2011EP2348050A1 Anti-glycated CD59 antibodies and uses thereof
07/27/2011EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies
07/27/2011EP2348047A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
07/27/2011EP2348046A1 NPC1L1 (NPC3) and methods of use thereof
07/27/2011EP2348045A1 Receptor, use of same and murine antibody
07/27/2011EP2348043A1 APO-2 ligand variants and uses thereof
07/27/2011EP2348042A1 Modified amyloid beta peptide
07/27/2011EP2348041A1 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
07/27/2011EP2348040A1 Replikin peptides and uses thereof
07/27/2011EP2348036A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
07/27/2011EP2348035A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
07/27/2011EP2348034A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
07/27/2011EP2347793A1 Method for regenerating hair follicles by suppressing a gene with hair follicle formation-inhibiting ability or by activating a gene with hair follicle formation - inducing ability
07/27/2011EP2347768A1 Novel use application of sugar chain-recognizing receptor
07/27/2011EP2347014A2 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny
07/27/2011EP2347009A2 Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
07/27/2011EP2346996A1 Transfection with magnetic nanoparticles and ultrasound
07/27/2011EP2346995A2 Gene therapy vectors and cytosine deaminases
07/27/2011EP2346994A2 Non-human mammals for the production of chimeric antibodies
07/27/2011EP2346993A1 Efficient expression of truncated human rnaset2 in e.coli
07/27/2011EP2346992A1 Thermostable alcohol dehydrogenase derived from thermococcus guaymasensis
07/27/2011EP2346906A1 Conjugates of glp-1 agonists and uses thereof
07/27/2011EP2346905A1 Methods and compositions for treatment of myotonic dystrophy
07/27/2011EP2346894A1 Thermostable cellulase and methods of use
07/27/2011EP2346883A2 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
07/27/2011EP2346606A1 Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
07/27/2011EP2346526A2 Compositions of and methods of using ligand dimers
07/27/2011EP2067031B1 Rapid in vivo model for angiogenesis
07/27/2011EP1989311B1 Stomatal guard cell specific promoter
07/27/2011EP1956084B1 Use of glucose isomerase mutants
07/27/2011EP1832654B1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody
07/27/2011EP1817061B1 Electroporation of mycobacterium and overexpression of antigens in mycobacteria
07/27/2011EP1811027B1 Polynucleotide for production of recombinant protein by silkworm
07/27/2011EP1761557B1 Novel gene products from bacillus licheniformis forming or decomposing polyamino acids and improved biotechnological production methods based thereon
07/27/2011EP1732946B1 Dimeric fusion proteins and materials and methods for producing them
07/27/2011EP1664312B1 Rodent expression systems utilising polyoma virus and epstein barr virus sequences
07/27/2011EP1649022B1 Wheat with altered branching enzyme activity and starch and starch containing products derived thereform
07/27/2011EP1616013B1 Methods and means for increasing the tolerance of plants to stress conditions
07/27/2011EP1599582B1 Method for the production of polyunsaturated fatty acids
07/27/2011EP1599578B1 Methods for preventing gluconoylation of proteins
07/27/2011EP1560931B1 Functional and hyperfunctional sirna
07/27/2011EP1558645B1 Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
07/27/2011EP1435993B1 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire
07/27/2011EP1434854B1 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof